How It All Started ?
The First step is always challenging
Our journey began in 2020, during a time when the world was grappling with an unprecedented pandemic. COVID-19 caused significant turmoil globally, with medicines being excessively priced and often unavailable when urgently needed. We witnessed many individuals in India losing their lives due to the high costs of treatment and medications. Moreover, the prevalence of low-quality medicines made from inferior raw materials had a considerable impact on people’s lives, particularly in tier 3 cities and beyond. In response to this crisis, we decided to create lab-tested medicines and provide them at affordable prices to tier 2 cities and above.
Who are we?
We Are A Passionate Team Of Creative Minds
We are a dedicated team of creative individuals committed to enhancing human lives by boosting the happiness index in everyone’s lifestyle. Our team boasts a wealth of knowledge, with an average of over 18 years of experience in the pharmaceutical sector. Recruited from the top 10 pharmaceutical companies in India, we are united by a shared vision and mission. With our commitment, we strive to implement the best processes and business practices in the industry.
M.D. & C.E.O.
Youthful Yet Experienced With Well-Defined Goals
Following the Lock Down event on November 6, 2020, and after several months of research and discussions with pharmaceutical industry experts to identify existing gaps, Mr. Jigar Trivedi, Managing Director and Chief Executive Officer, has devised a solid plan to enter the industry. With multiple degree of Science & IT professional, he has mentored and achieved numerous successes throughout his career. Driven by a vision to transform the industry through technology, he initially established a set of processes and built a robust system that ensures timely deliveries. With his predictive data analytics model, he consistently optimizes the company’s operations to run efficiently with minimal resources while maximising output. His management expertise and technological background have positioned the company ahead of other startups within the pharmaceutical sector.
With his extensive experience, he is instrumental in shaping the future of Furbo Pharmaceuticals in the industry. Under his leadership and supportive approach, the organization is poised to reach new levels of success. As a visionary committed to the well-being of people, he has entered the pharmaceutical sector. His promising business strategies and previous achievements will enable Furbo to thrive effectively.
Our Investors
Collaborating Towards A Shared Objective.
We are proud to have Mr. Shashin Trivedi, the owner of Jasmin Mobile Infinite Trade Private Limited, a talented singer and renowned investor, join us from the very beginning. Together with Mr. Jigar Trivedi’s management expertise and technology background, they have made a significant impact in the market.
Mr. Shashin Trivedi is a transformative leader with over 30 years of deep understanding of customer needs, making him exceptional at elevating businesses to new heights.
With his expert guidance and leadership, Furbo Pharmaceuticals is poised to make a meaningful difference in the pharmaceutical industry. Together we are committed to advancing healthcare by creating innovative solutions that genuinely enhance people’s lives.
Our Journey So Far
06 Nov 2020: Inception Date. We celebrate this day as Furbo Day, and to date, we have enjoyed three Furbo Day celebrations as we approach our fourth.
Following a market survey, we launched our product range in the general segment along with a sales force with a launch in 10 cities of Gujarat.
Cepofur, launched by Furbo Pharma, is an antibiotic medicine designed to combat bacterial infections effectively. As a part of Furbo Pharma’s expanding product line, Cepofur showcases the company’s dedication to innovation and quality in healthcare, offering reliable treatment solutions to improve patient outcomes worldwide.
Due to our rapid inception, product quality, and competitive pricing, we received recognition from the Industry Outlook Magazine with the “Best Startup Award” of 2021 for providing exceptional value to our clients and partners.
Within just one year of sales operations, we reached the milestone of selling 1 million tablets to our valued patients.
Furbo Pharma is thrilled to introduce MxFurCV, our latest antibiotic featuring Amoxicillin 500 mg and Potassium Clavulanate 125 mg. This advanced formulation is designed to effectively combat a wide range of bacterial infections. MxFurCV reflects our ongoing commitment to delivering high-quality, reliable healthcare solutions for improved patient outcomes.
Furbo Pharma unveils its latest product line, including five cutting-edge Multivitamin & Nutritional Supplements and the new Pain Relief Injection, Furdol AQ. This exciting addition to our portfolio highlights our dedication to providing comprehensive health solutions, aimed at boosting overall wellness and effective pain management.
Furbo Pharma proudly observes a substantial increase in our prescriber base. This development highlights the expanding trust and recognition of our products within the medical community. It signifies our commitment to delivering effective solutions and enhancing patient care, driving our continued success and growth in the healthcare field.
Launch of Business Associate model to accelerate the execution of our vision.